Lv1
40 积分 2022-07-18 加入
Safety and efficacy of once-weekly efruxifermin versus placebo in non-alcoholic steatohepatitis (HARMONY): a multicentre, randomised, double-blind, placebo-controlled, phase 2b trial
8天前
已完结
A Phase 3, Randomized, Controlled Trial of Resmetirom in NASH with Liver Fibrosis
8天前
已完结
Olezarsen for Hypertriglyceridemia in Patients at High Cardiovascular Risk
9天前
已完结
Olezarsen, Acute Pancreatitis, and Familial Chylomicronemia Syndrome
9天前
已完结
Semaglutide in Patients with Obesity-Related Heart Failure and Type 2 Diabetes
9天前
已完结
Orexin Receptor Antagonists and Insomnia
11天前
已完结
Rusfertide for the treatment of iron overload in HFE-related haemochromatosis: an open-label, multicentre, proof-of-concept phase 2 trial
16天前
已完结
Efficacy and safety of the muscarinic receptor agonist KarXT (xanomeline–trospium) in schizophrenia (EMERGENT-2) in the USA: results from a randomised, double-blind, placebo-controlled, flexible-dose phase 3 trial
20天前
已完结
In vivo engineering of CAR T cell therapies
24天前
已关闭
Drug targeting in psychiatric disorders — how to overcome the loss in translation?
24天前
已完结
